Please wait while we open this resource.
K
Clinical reviews
SGLT2 INHIBITORS IN PATIENTS WITH HEART FAILURE AND CHRONIC KIDNEY DISEASE
Copenhagen University Hospital Rigshospitalet
PDF3 pages277 KB
SGLT2 inhibitors have emerged as a critical treatment option for patients with heart failure and chronic kidney disease, supported by substantial clinical trial evidence. The document emphasizes the need for effective strategies to identify and treat patients who could benefit from these medications, particularly those without specialist care. It also addresses the importance of understanding the cost-effectiveness of SGLT2 inhibitors across different patient subgroups and the potential for improving public health outcomes through better implementation strategies.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology